Chronic inflammation, immune-modulating medications, and altered metabolic pathways can all affect GLP-1 response
Another study published in JAMA Network Open found that patients taking Semaglutide achieved greater mean percent change in body weight compared with those taking a placebo (-5% vs -2%)
However, during the initial weeks particularly around dose increases mild fatigue is not uncommon and may be related to reduced caloric intake or the body adapting to altered metabolism
Rather than functioning as a transactional service, the program emphasizes continuity and accountability across the treatment lifecycle
If you have lost weight in the past only to have it return, compounded Semaglutide/B12 and compounded Tirzepatide/B12 may help you lose weight and keep it off
After that, they will assess your condition and plan dose escalation accordingly